These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7505361

  • 1. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
    Nakazawa M, Ishihara T, Takahashi Y, Okuhira M, Imai S.
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
    [Abstract] [Full Text] [Related]

  • 2. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS, Ludden CT, Frederick CM, Bush LR, Ribeiro LG.
    J Cardiovasc Pharmacol; 1984 Oct; 6(6):1067-75. PubMed ID: 6084762
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Midazolam's effects on myocardial load and coronary perfusion: reduced regional O2 consumption and lactate production during ischemia in dogs.
    Sidi A, Rush W.
    J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):302-9. PubMed ID: 8061264
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS, Kass DA, Pak PH, Maughan WL, Fetics B, Hare JM.
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [Abstract] [Full Text] [Related]

  • 11. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
    Ikeo T, Yabana H, Kurosawa H, Kaburaki M, Kikkawa K, Narita H, Murata S, Yamaguchi I.
    Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
    Seymour AA, Mazack EK.
    Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.